MedPath

Inspire® Upper Airway Stimulation (UAS) System: CE Certificate Number 562872 German Post Market Study

Conditions
G47.31
Registration Number
DRKS00006328
Lead Sponsor
Inspire Medical Systems, Inc
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
30
Inclusion Criteria

1. Likely suffer moderate-to-severe OSA based on history and physical, or have an established diagnosis of OSA (= 15 AHI<65) based on a prior in-lab Polysomnography
2. Willing and capable to have stimulation hardware permanently implanted, and to use the patient programmer to activate the stimulation
3. Willing and capable to return for all follow-up visits and conduct sleep studies at home, including the evaluation procedures and filling out questionnaires
4. Willing and capable of providing informed consent

Exclusion Criteria

1. Any anatomical finding that would compromise the performance of upper airway stimulation, such as the presence of complete concentric collapse of the soft palate
2. Have any condition or procedure that has compromised neurological control of the upper airway
3. Unable or do not have the necessary assistance to operate the patient programmer
4. Pregnant or plan to become pregnant
5. Require magnetic resonance imaging (MRI)
6. Have an implantable device that may be susceptible to unintended interaction with the Inspire system.
7. Body Mass Index (BMI) of > 35
8. Central + mixed apneas > 25% of the total apnea–hypopnea index (AHI)
9. Any chronic medical illness or condition that contraindicates a surgical procedure under general anesthesia, as judged by the clinical study Investigator
10. Has a terminal illness with life expectancy < 12 months
11. Active psychiatric disease (psychotic illness, major depression, or acute anxiety attacks) which prevents subject compliance with the requirements of the investigational study testing
12. Any other reason the investigator deems subject is unfit for participation in the study

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath